stonks4u
Sign up free
ATHA logo

ATHA Athira Pharma, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$6.75
-0.44 (-6.12%)

Athira Pharma, Inc., a biopharmaceutical firm in advanced clinical development and based in Bothell, Washington, focuses on creating small molecule treatments designed to revitalize neuronal function and decelerate neurological decline. Its primary therapeutic candidate, ATH-1017, is a unique small molecule that modulates HGF/MET and is capable of crossing the blood-brain barrier. This compound is…

Market Cap: $26.62Mleonabio.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

120
100107113120
Aug 11Aug 12

Quote

Day Range
$6.61 – $7.35
52-Week Range
$2.20 – $8.36
Volume
$70.3K
Market Cap
$26.62M
50-Day Avg
$5.48
200-Day Avg
$4.03
Prev Close
$7.19
Open
$7.30

Valuation & Ratios

P/E Ratio
-0.31
EPS
$-24.70
P/B Ratio
1.16
P/S Ratio
0.00
Debt/Equity
0.03
Current Ratio
1.88
Dividend Yield
+0.0%
Gross Margin
+0.0%

Returns & Efficiency

Return on Equity
-380.0%
Return on Assets
-114.6%
FCF Yield
-141.3%
EV/EBITDA
-56.15

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$0.00$-105.61M$-24.70
2024$0.00$-96.94M$-25.20
2023$0.00$-117.67M$-30.90
2022$0.00$-95.64M$-25.30
2021$0.00$-54.85M$-14.90

Social Signal Score

61
5d
61
2 mentions
—
30d
61
2 mentions
—
60d
61
2 mentions
—
90d
61
2 mentions
—
news: 2

Earnings

3of 8 quarters beat consensus

Typical surprise -24.2% (median, so one quarter with a near-zero estimate can't distort it)

  • Fri, Aug 14$-0.80 vs $-0.60miss
  • Thu, May 7$-1.73 vs $-1.90beat
  • Wed, Feb 25$-3.90 vs $-0.58miss
  • Thu, Nov 6$-1.68 vs $-1.06miss
  • Thu, Aug 7$-1.80 vs $-1.80beat
  • Fri, May 9$-0.23 vs $-0.20miss

Estimates and results for ATHA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

ATHAhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (2)

  • Newsnewsfilecorp.com·3d ago·Positive

    Athena Provides Drilling Update from Excelsior Springs, Nevada Toronto, Ontario--(Newsfile Corp. - August 12, 2026) - Athena Gold Corporation (CSE: ATHA) (OTCQB: AHNRF) ("Athena" or the "Company") is pleased to provide an exploration update from its Excelsior Springs Project ("Excelsior" or the "Project") in Nevada. Mammoth Minerals Limited (ASX: M79) ("Mammoth") has been aggressively exploring Excelsior pursuant to its option agreement to earn an 80% interest in the Project over five years, pro

    View source ↗
  • Newsnewsfilecorp.com·4d ago·Neutral

    Athena Gold Further Expands Forester Project near Musselwhite, Ontario Toronto, Ontario--(Newsfile Corp. - August 11, 2026) - Athena Gold Corporation (CSE: ATHA) (OTCQB: AHNRF) ("Athena" or the "Company") is pleased to announce that it has further consolidated its land position at its 100%-owned Forester project in Ontario's Musselwhite Gold Camp. Through recent map staking, the Company acquired an additional 6,088 hectares of contiguous mining claims, expanding the project by approximately 69%

    View source ↗